Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will participate in two upcoming virtual investor conferences. The first is the Jefferies London Healthcare Conference on November 16, 2021, scheduled for 11:20 – 11:55 a.m. ET. The second is the Evercore ISI HealthCONx Conference on November 30, 2021, from 2:40 – 3:25 p.m. ET. Webcasts of the presentations can be accessed on their website, with replays available for 30 days. Jazz is a biopharmaceutical company based in Dublin, focusing on innovative treatments in neuroscience and oncology.

DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will virtually participate in the following upcoming investor conferences:

Jefferies London Healthcare Conference on Tuesday, November 16, 2021

• The presentation is scheduled for 11:20 – 11:55 a.m. ET / 4:20 – 4:55 p.m. GMT

Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021

• The presentation is scheduled for 2:40 – 3:25 p.m. ET / 7:40 – 8:25 p.m. GMT

Jazz will virtually participate in both conferences and webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com. Replays of the webcasts will be available on the website for 30 days.  

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com  
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 697 2141
U.S. +1 215 867 4948

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-november-investor-conferences-301420266.html

SOURCE Jazz Pharmaceuticals plc

FAQ

What investor conferences is Jazz Pharmaceuticals participating in November 2021?

Jazz Pharmaceuticals will participate in the Jefferies London Healthcare Conference on November 16 and the Evercore ISI HealthCONx Conference on November 30, 2021.

What is the schedule for Jazz Pharmaceuticals' presentation at the Jefferies Conference?

The presentation at the Jefferies London Healthcare Conference is scheduled for November 16, 2021, from 11:20 – 11:55 a.m. ET.

What time will Jazz Pharmaceuticals present at the Evercore ISI Conference?

The presentation at the Evercore ISI HealthCONx Conference is set for November 30, 2021, from 2:40 – 3:25 p.m. ET.

Where can I watch the Jazz Pharmaceuticals conference presentations?

Webcasts of Jazz Pharmaceuticals' presentations will be available on their Investors section of the website, with replays for 30 days.

What is the main focus of Jazz Pharmaceuticals?

Jazz Pharmaceuticals is dedicated to developing life-changing medicines in the fields of neuroscience and oncology.